Dare Bioscience, Inc.
DARE- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001401914
No open-market purchases or sales by Dare Bioscience, Inc. insiders were filed in the last 90 days; 27 institutions reported holding it in 13F filings for Q2 2026, worth $2.75M in total; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Dare Bioscience, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Dare Bioscience, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Grossman Jessica D. | Director | 26,066 | Jul 2, 2026 | 2 |
| Kelley Susan L. | Director | 23,696 | Jul 2, 2026 | 2 |
| Matz Gregory W | Director | 30,847 | Jul 2, 2026 | 2 |
| Rastetter William H | Director | 39,721 | Jul 2, 2026 | 2 |
| Steele Robin Joan | Director | 47,055 | Jul 2, 2026 | 2 |
| Johnson Sabrina Martucci | Chef Executive Officer | – | Feb 20, 2026 | 2 |
| Haring-Layton MarDee | Chief Accounting Officer | – | Feb 2, 2026 | 1 |
| Fair John A | Chief Commercial Officer | – | Mar 14, 2024 | 0 |
| Blanchard Cheryl R | Director | – | Jun 21, 2023 | 0 |
| Ononye-Onyia Sophia Nnenna | Director | – | Jun 21, 2023 | 0 |
| Walters-Hoffert Lisa | Chief Financial Officer | – | Jan 26, 2023 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
No insider trades match these filters.